OQROGet OQRO Pro
Insider trade

Aardvark Therapeutics (AARD)CEO bought ~$62K

Tien-li Lee, CEO at Aardvark Therapeutics, bought ~$62K of Aardvark Therapeutics shares.

~$62K
Approx. value · 6,500 sh @ $9.51
1.54M
Holds after · shares reported
Traded
Sep 15, 2025
Filed
Sep 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 9, 2025InsiderCFO purchased ~$48K of AARD shares in the open market
  2. Sep 10, 2025InsiderCEO purchased ~$71K of AARD shares in the open market
  3. Sep 11, 2025InsiderCEO purchased ~$47K of AARD shares in the open market
  4. Sep 12, 2025InsiderCEO purchased ~$43K of AARD shares in the open market
  5. Sep 15, 2025 · this disclosureInsiderCEO purchased ~$62K of AARD shares in the open market

What came next

  1. Sep 15, 2025InsiderCEO purchased ~$35K of AARD shares in the open market
  2. Nov 13, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aardvark Therapeutics

OQRO holds no insider, Congress, fund or contract record for Aardvark Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AARD page.

Other recent filings by Tien-li Lee, Chief Executive Officer

The full history of Tien-li Lee, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Aardvark Therapeutics

Everything OQRO holds on this company is on its AARD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data